FDA extends deadline for e-cigarette review due to coronavirus pandemic

FDA extends deadline for e-cigarette review due to coronavirus pandemic



The Food and Drug Administration (FDA) granted a four-month extension for electronic cigarette companies to submit their application materials regarding vaping products after the coronavirus pandemic has upended the companies' opportunity to gather research.